Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

This study has been completed.
Information provided by:
GlaxoSmithKline Identifier:
First received: August 4, 2005
Last updated: September 29, 2011
Last verified: September 2011
This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about chickenpox disease.

Condition Intervention Phase
Biological: Chickenpox infection
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: An Open, Prospective, Non-prophylactic, Non Therapeutic Study for the Detection and Characterisation of Varicella Zoster Virus Collected From Dermal Lesions of Patients Who Are Diagnosed of Having Varicella

Resource links provided by NLM:

Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • VZV DNA per clinical sample collected

Study Start Date: June 2005
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:
The study involves NO therapeutic or prophylactic treatment nor further observation of the patients. There is no product to be tested in this study.

Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Pediatric patients who are diagnosed of having varicella and are presenting varicella dermal lesions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00127608

Czech Republic
GSK Investigational Site
Praha 8, Czech Republic, 180 81
Sponsors and Collaborators
Study Director: GSK Clinical Trials GlaxoSmithKline
  More Information

Responsible Party: Cheri Hudson; Clinical Disclosure Advisor, GSK Clinical Disclosure Identifier: NCT00127608     History of Changes
Other Study ID Numbers: 103815
Study First Received: August 4, 2005
Last Updated: September 29, 2011

Additional relevant MeSH terms:
Herpes Zoster
Herpesviridae Infections
DNA Virus Infections
Virus Diseases processed this record on May 24, 2017